טוען...
The New FDA Real-World Evidence Program to Support Development of Drugs and Biologics
FDA has launched a Real World Evidence (RWE) Program for using real-world evidence (RWE) to help support new indications for already approved drugs or biologics and postapproval studies. The plan also includes stakeholder engagement efforts, demonstration projects, leadership activities, and develop...
שמור ב:
| הוצא לאור ב: | J Diabetes Sci Technol |
|---|---|
| מחבר ראשי: | |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
SAGE Publications
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7196856/ https://ncbi.nlm.nih.gov/pubmed/30862182 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1932296819832661 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|